1-11 of 11
Duane E. Johnson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The combination of Cox-2 and EGF serve as potential prognostic biomarkers for hormone refractory prostate cancer

Free
Kitani A. Parker-Johnson, Nerimiah L. Emmett, Jeremy D. Daigle, Anthony L. Depass, Walter Rayford, Bruce A. Jackson, Duane E. Johnson
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1195.
Published: 01 May 2005
View articletitled, The combination of Cox-2 and EGF serve as potential prognostic biomarkers for hormone refractory prostate cancer
Journal Articles

Novel DJ56 causes tumor reduction in ER+ breast cancer cells

Free
Tiffany Griffin, Byron Knowles, Kitani A. Parker-Johnson, Nerimiah L. Emmett, Emory Minnard, Duane E. Johnson
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1358.
Published: 01 May 2005
View articletitled, Novel DJ56 causes tumor reduction in ER+ breast cancer cells
Journal Articles

Microarray analyses reveal prostaglandin pathway as target for novel DJ compounds during antiproliferation of human prostate cancer cells

Free
Kitani A. Parker-Johnson, Bruce A. Jackson, Jeremy D. Daigle, Guoshen Wang, Nerimiah L. Emmett, Duane E. Johnson
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 383.
Published: 01 April 2004
View articletitled, Microarray analyses reveal prostaglandin pathway as target for novel DJ compounds during antiproliferation of human prostate cancer cells
Journal Articles

Novel DJ compounds significantly decrease the expression of transforming growth factor beta-3 gene in human prostate cancer cell line LNCaP using microarray

Free
Jeremy D. Daigle, Kitani A. Parker-Johnson, Courtney White, Guoshen Wang, Nerimiah L. Emmett, Duane E. Johnson
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 394.
Published: 01 April 2004
View articletitled, Novel DJ compounds significantly decrease the expression of transforming growth factor beta-3 gene in human prostate cancer cell line LNCaP using microarray
Journal Articles

Pharmacologic Indicators of Antitumor Efficacy for Oncolytic Virotherapy

Free
G. William Demers, Duane E. Johnson, Van Tsai, Shu-Fen Wen, Erlinda Quijano, Todd Machemer, Jennifer Philopena, Murali Ramachandra, John A. Howe, Paul Shabram, Robert Ralston, Heidrun Engler
Journal: Cancer Research
Cancer Res (2003) 63 (14): 4003–4008.
Published: 21 July 2003
View articletitled, Pharmacologic Indicators of Antitumor Efficacy for Oncolytic Virotherapy
Open the PDF for Pharmacologic Indicators of Antitumor Efficacy for Oncolytic Virotherapy in another window
Journal Articles

Suppression of Tumorigenicity of Glioblastoma Cells by Adenovirus-mediated MMAC1/PTEN Gene Transfer

Free
I. Wayne Cheney, Duane E. Johnson, Mei-Ting Vaillancourt, Jenny Avanzini, Alyssa Morimoto, G. William Demers, Ken N. Wills, Paul W. Shabram, Joseph B. Bolen, Sean V. Tavtigian, Robert Bookstein
Journal: Cancer Research
Cancer Res (1998) 58 (11): 2331–2334.
Published: 01 June 1998
View articletitled, Suppression of Tumorigenicity of Glioblastoma Cells by Adenovirus-mediated MMAC1/PTEN Gene Transfer
Open the PDF for Suppression of Tumorigenicity of Glioblastoma Cells by Adenovirus-mediated MMAC1/PTEN Gene Transfer in another window
Journal Articles

Superiority of an Acid-labile Daunorubicin-Monoclonal Antibody Immunoconjugate Compared to Free Drug

Free
Robert O. Dillman, Duane E. Johnson, Daniel L. Shawler, James A. Koziol
Journal: Cancer Research
Cancer Res (1988) 48 (21): 6097–6102.
Published: 01 November 1988
View articletitled, Superiority of an Acid-labile Daunorubicin-Monoclonal Antibody Immunoconjugate Compared to Free Drug
Open the PDF for Superiority of an Acid-labile Daunorubicin-Monoclonal Antibody Immunoconjugate Compared to Free Drug in another window
Journal Articles

Inhibition of Human T-Cell Tumor Growth by T101-Ricin A-Chain in an Athymic Mouse Model

Free
John E. Leonard, Duane E. Johnson, Daniel L. Shawler, Robert O. Dillman
Journal: Cancer Research
Cancer Res (1988) 48 (17): 4862–4867.
Published: 01 September 1988
View articletitled, Inhibition of Human T-Cell Tumor Growth by T101-Ricin A-Chain in an Athymic Mouse Model
Open the PDF for Inhibition of Human T-Cell Tumor Growth by T101-Ricin A-Chain in an Athymic Mouse Model in another window
Journal Articles

Establishment of a Human B-Cell Tumor in Athymic Mice

Free
John E. Leonard, Duane E. Johnson, Ruth B. Felsen, Laura E. Tanney, Ivor Royston, Robert O. Dillman
Journal: Cancer Research
Cancer Res (1987) 47 (11): 2899–2902.
Published: 01 June 1987
View articletitled, Establishment of a Human B-Cell Tumor in Athymic Mice
Open the PDF for Establishment of a Human B-Cell Tumor in Athymic Mice in another window
Journal Articles

Preclinical Trials with Combinations and Conjugates of T101 Monoclonal Antibody and Doxorubicin

Free
Robert O. Dillman, Daniel L. Shawler, Duane E. Johnson, Damon L. Meyer, James A. Koziol, James M. Frincke
Journal: Cancer Research
Cancer Res (1986) 46 (10): 4886–4891.
Published: 01 October 1986
View articletitled, Preclinical Trials with Combinations and Conjugates of T101 Monoclonal Antibody and Doxorubicin
Open the PDF for Preclinical Trials with Combinations and Conjugates of T101 Monoclonal Antibody and Doxorubicin in another window
Journal Articles

Athymic Mouse Model of a Human T-Cell Tumor

Free
Robert O. Dillman, Duane E. Johnson, Daniel L. Shawler, Samuel E. Halpern, John E. Leonard, Philip L. Hagan
Journal: Cancer Research
Cancer Res (1985) 45 (11_Part_2): 5632–5636.
Published: 01 November 1985
View articletitled, Athymic Mouse Model of a Human T-Cell Tumor
Open the PDF for Athymic Mouse Model of a Human T-Cell Tumor in another window